Efficacy and cost-benefit analysis of risk-adaptive use of plerixafor for autologous hematopoietic progenitor cell mobilization
Author:
Publisher
Wiley
Subject
Hematology,Immunology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2011.03206.x/fullpdf
Reference40 articles.
1. Improving stem cell mobilization strategies: future directions;Bensinger;Bone Marrow Transplant,2009
2. PBPC collection techniques: standard versus large volume leukapheresis (LVL) in donors and in patients;Gasova;Transfus Apher Sci,2005
3. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy;Siena;J Clin Oncol,2000
4. What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant?;Jillella;Stem Cells Dev,2004
5. Bone marrow transplantation: prognostic factors of peripheral blood stem cell mobilization with cyclophosphamide and filgrastim (r-metHuG-CSF): the CD34+ cell dose positively affects the time to hematopoietic recovery and supportive requirements after high-dose chemotherapy;Sola;Hematology,1999
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Autologous peripheral blood stem cell harvest timing by absolute neutrophil count in children and young adult patients: Single-institute experience;Pediatrics & Neonatology;2024-08
2. Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma;Bone Marrow Transplantation;2024-07-31
3. Updates on the mobilization pipeline for hematopoietic stem cell collection;Journal of Clinical Apheresis;2023-09-25
4. On demand plerixafor is safe and effective for hematopoietic progenitor cell mobilization in patients with light chain amyloidosis at risk for mobilization failure with G-CSF alone;Bone Marrow Transplantation;2023-02-24
5. The effect of preemptive use of plerixafor on stem cell mobilization in patients with lymphoma and multiple myeloma;Marmara Medical Journal;2023-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3